US Bus Station.com
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates

Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates (from http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=d37dc77551be4d65a40165d93fa8c4de&url=https%3a%2f%2fwhnt.com%2fbusiness%2fpress-releases%2fglobenewswire%2f8618680%2finozyme-pharma-reports-second-quarter-2022-financial-results-and-provides-business-updates%2f&c=5072997953086139091&mkt=en-us)

The Website http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=d37dc77551be4d65a40165d93fa8c4de&url=https%3a%2f%2fwhnt.com%2fbusiness%2fpress-releases%2fglobenewswire%2f8618680%2finozyme-pharma-reports-second-quarter-2022-financial-results-and-provides-business-updates%2f&c=5072997953086139091&mkt=en-us opens up when you'll press the button below. It's content doesn't belong to us, and we're not responsible for it. If you don't think this content is appropriate, or if you're the owner of that website and do not wish to have your website displayed here, please just contact us.

- Recently reported positive preliminary biomarker and safety data from ongoing Phase 12 clinical trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency – - Appointed Kurt Gunter, M.D. as ...

US Bus Station.comInozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates

Click Here To Read The Rest Of The Article

US Bus Station.com
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates